| REVIEW ARTICLE |
|
| Year : 2020 | Volume
: 10
| Issue : 4 | Page : 255-258 |
|
|
Intraocular pressure reduction in glaucoma: Does every mmHg count?
Hari Jayaram
Glaucoma Service, Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; NIHR Moorfields Biomedical Research Centre, London, United Kingdom
Correspondence Address:
Dr. Hari Jayaram
Glaucoma Service, Moorfields Eye Hospital NHS Foundation Trust, London
United Kingdom
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/tjo.tjo_63_20
|
|
|
The reduction of intraocular pressure is currently the only known modifiable risk factor for the treatment of Glaucoma, which is the leading cause of irreversible worldwide blindness. This concise review discusses the evidence underpinning the reduction of intraocular pressure in the treatment of glaucoma, the role of target intraocular pressure in clinical practice and appraises clinical data supporting the concept that every mmHg of intraocular pressure reduction is important in reducing the risk of developing glaucoma and the progression of existing disease. Every mmHg in IOP reduction is important, with evidence showing an impact on both functional and structural progression but does not however explain all glaucoma risk.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
